Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 September 2016 |
Main ID: |
NCT00561236 |
Date of registration:
|
18/11/2007 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Does Intravitreal Injection of Triamcinolone Acetonide Impairs the Adrenal Function
|
Scientific title:
|
Low Dose (1mcg ) ACTH Stimulation Test for Assessment of the Hypothalamo- Pituitary- Adrenal Axis in Patients Treated With Intravitreal Injection of Triamcinolone Acetonide |
Date of first enrolment:
|
April 2007 |
Target sample size:
|
28 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT00561236 |
Study type:
|
Observational |
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Avraham Ishay, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Haemek Medical Center , Endocrine Institute |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- patients receiving intravitreous injection of triamcinolone 4mg
Exclusion Criteria:
- patients receiving steroids in any form, except by intravitreous administration
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Secondary Adrenal Insufficiency
|
Secondary ID(s)
|
002507EMC
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|